BioXcel Insider Rodriguez Javier Buys 35 Shares as Social‑Media Buzz Soars, Hinting at Near‑Term Pipeline Upside
Insider buying at BioXcel shows confidence ahead of earnings and FDA review, sparking 304% social‑media buzz and potential upside.
3 minutes to read



